A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimer's disease: a post hoc analysis (Q43237719)
Jump to navigation
Jump to search
scientific article published in February 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimer's disease: a post hoc analysis |
scientific article published in February 2010 |
Statements
1 reference
A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimer's disease: a post hoc analysis (English)
1 reference
Martin R Farlow
1 reference
Gus Alva
1 reference
Xiangyi Meng
1 reference
Jason T Olin
1 reference
1 February 2010
1 reference
1 reference
Identifiers
1 reference